| abstract |
The present application relates to new derivatives of 5-sulfanyl-4H-1, 2, 4-triazoles of the formula in which R1, R2 and R3 represent various variable groups and their preparation processes by parallel synthesis methods in liquid phase . As these products have a good affinity for certain subtypes of somatostatin receptors, they are particularly useful for treating pathological states or diseases in which one (or more) of the somatostatin receptors is (are) involved. The invention also relates to pharmaceutical compositions containing said products and their use for the preparation of a medicament. |